A Phase I Study of Pegylated Liposomal Doxorubicin Hydrochloride (Caelyx™) in Combination with Cyclophosphamide and Vincristine as Second-Line Treatment of Patients with Small-Cell Lung Cancer

2003 ◽  
Vol 5 (2) ◽  
pp. 107-112 ◽  
Author(s):  
Natasha B. Leighl ◽  
Ronald L. Burkes ◽  
Janet E. Dancey ◽  
Pedro G. Lopez ◽  
Brian P. Higgins ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Doxorubicin Hydrochloride ◽  
Small Cell Lung

scholarly journals A Phase I/II Study of GTI-2040 Plus Docetaxel as Second-Line Treatment in Advanced Non-small Cell Lung Cancer: A Study of the PMH Phase II Consortium

2009 ◽  
Vol 4 (9) ◽  
pp. 1163-1169 ◽  
Author(s):  
Natasha B. Leighl ◽  
Scott A. Laurie ◽  
Xueyu E. Chen ◽  
Peter Ellis ◽  
Frances A. Shepherd ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document